2018-2023 Global Psoriasis Therapeutics Market Report (Status and Outlook)

October 2018 | 118 pages | ID: 2FC1E180A52EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Psoriasis Therapeutics market for 2018-2023.

Psoriasis is considered to be a persistent skin disorder that is characterized mainly by skin irritation and scaly rashes where the skin cells multiply up to 10 times faster than normal. Psoriasis majorly affects the knees, elbows, and scalp. The major objective of the therapy for this disease is to stop the skin cells from growing so quickly. The therapeutic approach for psoriasis depends upon the severity and amount of skin affected by the same.
Over the next five years, LPI(LP Information) projects that Psoriasis Therapeutics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Psoriasis Therapeutics market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• TNF Inhibitors
• PDE4 Inhibitors
• Others

Segmentation by application:

• Oral
• Parenteral
• Topical

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Astellas Pharma Inc.
• AstraZeneca plc
• Boehringer Ingelheim GmbH
• F. Hofffmann-La Roche
• GlaxoSmithKline plc
• Merck & Co., Inc.
• Valeant Pharmaceuticals International, Inc.
• Biocon Limited
• Eli Lilly and Company
• G & W Laboratories Inc.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Psoriasis Therapeutics market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Psoriasis Therapeutics market by identifying its various subsegments.
• Focuses on the key global Psoriasis Therapeutics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Psoriasis Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Psoriasis Therapeutics submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Psoriasis Therapeutics Market Size 2013-2023
  2.1.2 Psoriasis Therapeutics Market Size CAGR by Region
2.2 Psoriasis Therapeutics Segment by Type
  2.2.1 TNF Inhibitors
  2.2.2 PDE4 Inhibitors
  2.2.3 Interleukin Blockers
  2.2.4 Others
2.3 Psoriasis Therapeutics Market Size by Type
  2.3.1 Global Psoriasis Therapeutics Market Size Market Share by Type (2013-2018)
  2.3.2 Global Psoriasis Therapeutics Market Size Growth Rate by Type (2013-2018)
2.4 Psoriasis Therapeutics Segment by Application
  2.4.1 Oral
  2.4.2 Parenteral
  2.4.3 Topical
2.5 Psoriasis Therapeutics Market Size by Application
  2.5.1 Global Psoriasis Therapeutics Market Size Market Share by Application (2013-2018)
  2.5.2 Global Psoriasis Therapeutics Market Size Growth Rate by Application (2013-2018)

3 GLOBAL PSORIASIS THERAPEUTICS BY PLAYERS

3.1 Global Psoriasis Therapeutics Market Size Market Share by Players
  3.1.1 Global Psoriasis Therapeutics Market Size by Players (2016-2018)
  3.1.2 Global Psoriasis Therapeutics Market Size Market Share by Players (2016-2018)
3.2 Global Psoriasis Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PSORIASIS THERAPEUTICS BY REGIONS

4.1 Psoriasis Therapeutics Market Size by Regions
4.2 Americas Psoriasis Therapeutics Market Size Growth
4.3 APAC Psoriasis Therapeutics Market Size Growth
4.4 Europe Psoriasis Therapeutics Market Size Growth
4.5 Middle East & Africa Psoriasis Therapeutics Market Size Growth

5 AMERICAS

5.1 Americas Psoriasis Therapeutics Market Size by Countries
5.2 Americas Psoriasis Therapeutics Market Size by Type
5.3 Americas Psoriasis Therapeutics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Psoriasis Therapeutics Market Size by Countries
6.2 APAC Psoriasis Therapeutics Market Size by Type
6.3 APAC Psoriasis Therapeutics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Psoriasis Therapeutics by Countries
7.2 Europe Psoriasis Therapeutics Market Size by Type
7.3 Europe Psoriasis Therapeutics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Psoriasis Therapeutics by Countries
8.2 Middle East & Africa Psoriasis Therapeutics Market Size by Type
8.3 Middle East & Africa Psoriasis Therapeutics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL PSORIASIS THERAPEUTICS MARKET FORECAST

10.1 Global Psoriasis Therapeutics Market Size Forecast (2018-2023)
10.2 Global Psoriasis Therapeutics Forecast by Regions
  10.2.1 Global Psoriasis Therapeutics Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Psoriasis Therapeutics Forecast by Type
10.8 Global Psoriasis Therapeutics Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Astellas Pharma Inc.
  11.1.1 Company Details
  11.1.2 Psoriasis Therapeutics Product Offered
  11.1.3 Astellas Pharma Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Astellas Pharma Inc. News
11.2 AstraZeneca plc
  11.2.1 Company Details
  11.2.2 Psoriasis Therapeutics Product Offered
  11.2.3 AstraZeneca plc Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 AstraZeneca plc News
11.3 Boehringer Ingelheim GmbH
  11.3.1 Company Details
  11.3.2 Psoriasis Therapeutics Product Offered
  11.3.3 Boehringer Ingelheim GmbH Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Boehringer Ingelheim GmbH News
11.4 F. Hofffmann-La Roche
  11.4.1 Company Details
  11.4.2 Psoriasis Therapeutics Product Offered
  11.4.3 F. Hofffmann-La Roche Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 F. Hofffmann-La Roche News
11.5 GlaxoSmithKline plc
  11.5.1 Company Details
  11.5.2 Psoriasis Therapeutics Product Offered
  11.5.3 GlaxoSmithKline plc Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 GlaxoSmithKline plc News
11.6 Merck & Co., Inc.
  11.6.1 Company Details
  11.6.2 Psoriasis Therapeutics Product Offered
  11.6.3 Merck & Co., Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Merck & Co., Inc. News
11.7 Valeant Pharmaceuticals International, Inc.
  11.7.1 Company Details
  11.7.2 Psoriasis Therapeutics Product Offered
  11.7.3 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Valeant Pharmaceuticals International, Inc. News
11.8 Biocon Limited
  11.8.1 Company Details
  11.8.2 Psoriasis Therapeutics Product Offered
  11.8.3 Biocon Limited Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Biocon Limited News
11.9 Eli Lilly and Company
  11.9.1 Company Details
  11.9.2 Psoriasis Therapeutics Product Offered
  11.9.3 Eli Lilly and Company Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Eli Lilly and Company News
11.10 G & W Laboratories Inc.
  11.10.1 Company Details
  11.10.2 Psoriasis Therapeutics Product Offered
  11.10.3 G & W Laboratories Inc. Psoriasis Therapeutics Revenue, Gross Margin and Market Share (2016-2018)
  11.10.4 Main Business Overview
  11.10.5 G & W Laboratories Inc. News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Psoriasis Therapeutics
Figure Psoriasis Therapeutics Report Years Considered
Figure Market Research Methodology
Figure Global Psoriasis Therapeutics Market Size Growth Rate 2013-2023 ($ Millions)
Table Psoriasis Therapeutics Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of TNF Inhibitors
Table Major Players of PDE4 Inhibitors
Table Major Players of Interleukin Blockers
Table Major Players of Others
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Psoriasis Therapeutics Market Size Market Share by Type (2013-2018)
Figure Global Psoriasis Therapeutics Market Size Market Share by Type (2013-2018)
Figure Global TNF Inhibitors Market Size Growth Rate
Figure Global PDE4 Inhibitors Market Size Growth Rate
Figure Global Interleukin Blockers Market Size Growth Rate
Figure Global Others Market Size Growth Rate
Figure Psoriasis Therapeutics Consumed in Oral
Figure Global Psoriasis Therapeutics Market: Oral (2013-2018) ($ Millions)
Figure Global Oral YoY Growth ($ Millions)
Figure Psoriasis Therapeutics Consumed in Parenteral
Figure Global Psoriasis Therapeutics Market: Parenteral (2013-2018) ($ Millions)
Figure Global Parenteral YoY Growth ($ Millions)
Figure Psoriasis Therapeutics Consumed in Topical
Figure Global Psoriasis Therapeutics Market: Topical (2013-2018) ($ Millions)
Figure Global Topical YoY Growth ($ Millions)
Table Global Psoriasis Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Global Psoriasis Therapeutics Market Size Market Share by Application (2013-2018)
Figure Global Psoriasis Therapeutics Market Size Market Share by Application (2013-2018)
Figure Global Psoriasis Therapeutics Market Size in Oral Growth Rate
Figure Global Psoriasis Therapeutics Market Size in Parenteral Growth Rate
Figure Global Psoriasis Therapeutics Market Size in Topical Growth Rate
Table Global Psoriasis Therapeutics Revenue by Players (2016-2018) ($ Millions)
Table Global Psoriasis Therapeutics Revenue Market Share by Players (2016-2018)
Figure Global Psoriasis Therapeutics Revenue Market Share by Players in 2017
Table Global Psoriasis Therapeutics Key Players Head office and Products Offered
Table Psoriasis Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Psoriasis Therapeutics Market Size by Regions 2013-2018 ($ Millions)
Table Global Psoriasis Therapeutics Market Size Market Share by Regions 2013-2018
Figure Global Psoriasis Therapeutics Market Size Market Share by Regions 2013-2018
Figure Americas Psoriasis Therapeutics Market Size 2013-2018 ($ Millions)
Figure APAC Psoriasis Therapeutics Market Size 2013-2018 ($ Millions)
Figure Europe Psoriasis Therapeutics Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Psoriasis Therapeutics Market Size 2013-2018 ($ Millions)
Table Americas Psoriasis Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table Americas Psoriasis Therapeutics Market Size Market Share by Countries (2013-2018)
Figure Americas Psoriasis Therapeutics Market Size Market Share by Countries in 2017
Table Americas Psoriasis Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table Americas Psoriasis Therapeutics Market Size Market Share by Type (2013-2018)
Figure Americas Psoriasis Therapeutics Market Size Market Share by Type in 2017
Table Americas Psoriasis Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Americas Psoriasis Therapeutics Market Size Market Share by Application (2013-2018)
Figure Americas Psoriasis Therapeutics Market Size Market Share by Application in 2017
Figure United States Psoriasis Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Canada Psoriasis Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Psoriasis Therapeutics Market Size Growth 2013-2018 ($ Millions)
Table APAC Psoriasis Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table APAC Psoriasis Therapeutics Market Size Market Share by Countries (2013-2018)
Figure APAC Psoriasis Therapeutics Market Size Market Share by Countries in 2017
Table APAC Psoriasis Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table APAC Psoriasis Therapeutics Market Size Market Share by Type (2013-2018)
Figure APAC Psoriasis Therapeutics Market Size Market Share by Type in 2017
Table APAC Psoriasis Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table APAC Psoriasis Therapeutics Market Size Market Share by Application (2013-2018)
Figure APAC Psoriasis Therapeutics Market Size Market Share by Application in 2017
Figure China Psoriasis Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Japan Psoriasis Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Korea Psoriasis Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Psoriasis Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure India Psoriasis Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Australia Psoriasis Therapeutics Market Size Growth 2013-2018 ($ Millions)
Table Europe Psoriasis Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table Europe Psoriasis Therapeutics Market Size Market Share by Countries (2013-2018)
Figure Europe Psoriasis Therapeutics Market Size Market Share by Countries in 2017
Table Europe Psoriasis Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table Europe Psoriasis Therapeutics Market Size Market Share by Type (2013-2018)
Figure Europe Psoriasis Therapeutics Market Size Market Share by Type in 2017
Table Europe Psoriasis Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Europe Psoriasis Therapeutics Market Size Market Share by Application (2013-2018)
Figure Europe Psoriasis Therapeutics Market Size Market Share by Application in 2017
Figure Germany Psoriasis Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure France Psoriasis Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure UK Psoriasis Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Italy Psoriasis Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Russia Psoriasis Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Spain Psoriasis Therapeutics Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Psoriasis Therapeutics Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Psoriasis Therapeutics Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Psoriasis Therapeutics Market Size Market Share by Countries in 2017
Table Middle East & Africa Psoriasis Therapeutics Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Psoriasis Therapeutics Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Psoriasis Therapeutics Market Size Market Share by Type in 2017
Table Middle East & Africa Psoriasis Therapeutics Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Psoriasis Therapeutics Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Psoriasis Therapeutics Market Size Market Share by Application in 2017
Figure Egypt Psoriasis Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Psoriasis Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Israel Psoriasis Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Psoriasis Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Psoriasis Therapeutics Market Size Growth 2013-2018 ($ Millions)
Figure Global Psoriasis Therapeutics arket Size Forecast (2018-2023) ($ Millions)
Table Global Psoriasis Therapeutics Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Psoriasis Therapeutics Market Size Market Share Forecast by Regions
Figure Americas Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure APAC Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure Europe Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure United States Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure Canada Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure Mexico Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure Brazil Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure China Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure Japan Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure Korea Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure India Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure Australia Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure Germany Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure France Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure UK Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure Italy Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure Russia Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure Spain Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure Egypt Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure South Africa Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure Israel Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure Turkey Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Figure GCC Countries Psoriasis Therapeutics Market Size 2018-2023 ($ Millions)
Table Global Psoriasis Therapeutics Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Psoriasis Therapeutics Market Size Market Share Forecast by Type (2018-2023)
Table Global Psoriasis Therapeutics Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Psoriasis Therapeutics Market Size Market Share Forecast by Application (2018-2023)
Table Astellas Pharma Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table Astellas Pharma Inc. Psoriasis Therapeutics Revenue and Gross Margin (2016-2018)
Figure Astellas Pharma Inc. Psoriasis Therapeutics Market Share (2016-2018)
Table AstraZeneca plc Basic Information, Head Office, Major Market Areas and Its Competitors
Table AstraZeneca plc Psoriasis Therapeutics Revenue and Gross Margin (2016-2018)
Figure AstraZeneca plc Psoriasis Therapeutics Market Share (2016-2018)
Table Boehringer Ingelheim GmbH Basic Information, Head Office, Major Market Areas and Its Competitors
Table Boehringer Ingelheim GmbH Psoriasis Therapeutics Revenue and Gross Margin (2016-2018)
Figure Boehringer Ingelheim GmbH Psoriasis Therapeutics Market Share (2016-2018)
Table F. Hofffmann-La Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table F. Hofffmann-La Roche Psoriasis Therapeutics Revenue and Gross Margin (2016-2018)
Figure F. Hofffmann-La Roche Psoriasis Therapeutics Market Share (2016-2018)
Table GlaxoSmithKline plc Basic Information, Head Office, Major Market Areas and Its Competitors
Table GlaxoSmithKline plc Psoriasis Therapeutics Revenue and Gross Margin (2016-2018)
Figure GlaxoSmithKline plc Psoriasis Therapeutics Market Share (2016-2018)
Table Merck & Co., Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table Merck & Co., Inc. Psoriasis Therapeutics Revenue and Gross Margin (2016-2018)
Figure Merck & Co., Inc. Psoriasis Therapeutics Market Share (2016-2018)
Table Valeant Pharmaceuticals International, Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Revenue and Gross Margin (2016-2018)
Figure Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Market Share (2016-2018)
Table Biocon Limited Basic Information, Head Office, Major Market Areas and Its Competitors
Table Biocon Limited Psoriasis Therapeutics Revenue and Gross Margin (2016-2018)
Figure Biocon Limited Psoriasis Therapeutics Market Share (2016-2018)
Table Eli Lilly and Company Basic Information, Head Office, Major Market Areas and Its Competitors
Table Eli Lilly and Company Psoriasis Therapeutics Revenue and Gross Margin (2016-2018)
Figure Eli Lilly and Company Psoriasis Therapeutics Market Share (2016-2018)
Table G & W Laboratories Inc. Basic Information, Head Office, Major Market Areas and Its Competitors
Table G & W Laboratories Inc. Psoriasis Therapeutics Revenue and Gross Margin (2016-2018)
Figure G & W Laboratories Inc. Psoriasis Therapeutics Market Share (2016-2018)